Endothelium-derived vasoconstriction by purines and pyrimidines

Circ Res. 2008 Nov 7;103(10):1056-7. doi: 10.1161/CIRCRESAHA.108.187963.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adenine Nucleotides / blood
  • Adenine Nucleotides / pharmacology*
  • Animals
  • Antihypertensive Agents / pharmacology
  • Blood Pressure / drug effects
  • Cells, Cultured
  • Endothelial Cells / cytology
  • Endothelial Cells / metabolism*
  • Humans
  • Kidney / blood supply
  • Kidney / metabolism
  • Peptides, Cyclic / pharmacology
  • Purinergic P2 Receptor Agonists*
  • Rats
  • Receptors, Purinergic P2 / metabolism
  • Receptors, Purinergic P2X
  • Vasoconstriction / drug effects*
  • Vasoconstrictor Agents / blood
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Adenine Nucleotides
  • Antihypertensive Agents
  • Peptides, Cyclic
  • Purinergic P2 Receptor Agonists
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2X
  • Vasoconstrictor Agents
  • adenosine 5'-tetraphosphate
  • cyclo(Trp-Asp-Pro-Val-Leu)